Flinton Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$11.8M Buy
105,230
+476
+0.5% +$53K 0.37% 51
2019
Q2
$11.6M Buy
104,754
+6,868
+7% +$809K 0.37% 55
2019
Q1
$12.7M Buy
97,886
+38,998
+66% +$4.74M 0.42% 48
2018
Q4
$6.81M Buy
58,888
+11,560
+24% +$1.29M 0.26% 89
2018
Q3
$5.08M Sell
47,328
-1,394
-3% -$139K 0.16% 127
2018
Q2
$4.16M Buy
48,722
+3,672
+8% +$302K 0.13% 148
2018
Q1
$3.48M Sell
45,050
-6,358
-12% -$512K 0.12% 155
2017
Q4
$4.34M Buy
51,408
+13,566
+36% +$1.15M 0.15% 133
2017
Q3
$3.24M Sell
37,842
-3,536
-9% -$290K 0.12% 149
2017
Q2
$3.4M Sell
41,378
-3,128
-7% -$255K 0.12% 145
2017
Q1
$3.74M Sell
44,506
-26,282
-37% -$2.11M 0.14% 134
2016
Q4
$5.21M Buy
+70,788
New +$5.27M 0.23% 89

Other funds holding LLY

Flinton Capital Management's LLY Position: Q3 2019 in Review

Flinton Capital Management increased its Eli Lilly (LLY) stake by 0.45% in Q3 2019, buying an estimated $53K and bringing the position to 105,230 shares worth $11.8M. The position accounts for 0.37% of the portfolio, ranked #51.

Flinton Capital Management first reported a position in LLY in Q4 2016 and has held it in 12 quarters since. The position peaked at $12.7M in Q1 2019. 1,524 funds tracked by Wall St. Rank hold LLY as of Q3 2019.

  • Flinton Capital Management held 105,230 shares of Eli Lilly worth $11.8M as of Q3 2019.
  • Flinton Capital Management bought 476 Eli Lilly shares in Q3 2019, an estimated $53K.
  • Eli Lilly made up 0.37% of Flinton Capital Management's portfolio in Q3 2019, its #51 holding.
  • Flinton Capital Management first reported a position in Eli Lilly in Q4 2016 and has held it in 12 quarters since.
  • Flinton Capital Management's Eli Lilly position peaked at $12.7M in Q1 2019.
  • 1,524 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2019.

Based on Flinton Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.